Risedronate sodium hemipentahydrate;Risedronate Sodium 2.5H2O;Sodium hydrogen(1-hydroxy-1-phosphono-2-(pyridin-3-yl)ethyl)phosphonate hydrate(2:2:5);Sodium risedronate hemipentahydrate;Actonel (TN);disodium;hydroxy-(1-hydroxy-1-phosphono-2-pyridin-3-ylethyl)phosphinate;pentahydrate;Risedronate Sodium 2.5 Hydrate;Monosodium 1-Hydroxy-2-(3-pyridyl)ethylidene-1,1-diphosphonate;Monosodium 1-Hydroxy-2-(3-pyridyl)ethylidene-1,1-diphosphonate;Sodium trihydrogen (1-hydroxy-2-(3-pyridyl)ethylidene)diphosphonate hemi-pentahydrate;Phosphonic acid, p,p'-(1-hydroxy-2-(3-pyridinyl)ethylidene)bis-, sodium salt, hydrate (2:2:5);FT-0660934
Risedronate sodium 2.5-hydrate is a fully characterized chemical compound used as a reference standard of API Risedronic Acid. The standard offered is compliant with regulatory guidelines. Risedronate sodium 2.5-hydrate is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 329003-65-8
Related products
Risedronate USP Related Compound A (Risedronate EP Impurity B)
M.F.
M.W. 283.11
CAT# AR-R01671
CAS# 105462-23-5
